Cargando…
Characterization of microbiome and metabolite analyses in patients with metabolic associated fatty liver disease and type II diabetes mellitus
BACKGROUND: State-of-the-art renewal has indicated the improvement of diagnostics of patients with metabolic associated fatty liver disease (MAFLD) and/or type II diabetes mellitus (T2DM) by dissecting the clinical characteristics as well as genomic analysis. However, the deficiency of the character...
Autores principales: | Yang, Qiuping, Zhang, Leisheng, Li, Qian, Gu, Man, Qu, Qiu, Yang, Xinglong, Yi, Qinghua, Gu, Kunli, Kuang, Linli, Hao, Mei, Xu, Jing, Yang, Hongju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011963/ https://www.ncbi.nlm.nih.gov/pubmed/35421921 http://dx.doi.org/10.1186/s12866-022-02526-w |
Ejemplares similares
-
Serum miR-195-5p Exhibits Clinical Significance in the Diagnosis of Essential Hypertension with Type 2 Diabetes Mellitus by Targeting DRD1
por: Hu, Yueyan, et al.
Publicado: (2021) -
Role of microbiome and its metabolite, short chain fatty acid in prostate cancer
por: Yang, Hee Jo, et al.
Publicado: (2023) -
Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus
por: Lyu, Xuejing, et al.
Publicado: (2023) -
Characteristics of Gut Microbiome and Its Metabolites, Short-Chain Fatty Acids, in Children With Idiopathic Short Stature
por: Li, Lin, et al.
Publicado: (2022) -
Silibinin reduces in vitro methane production by regulating the rumen microbiome and metabolites
por: Liu, Rui, et al.
Publicado: (2023)